NASDAQ:CLOV Clover Health Investments (CLOV) Stock Price, News & Analysis $4.93 +0.10 (+2.07%) Closing price 11/10/2026 04:00 PM EasternExtended Trading$4.92 -0.01 (-0.30%) As of 04:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Clover Health Investments Stock (NASDAQ:CLOV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CLOV alerts:Sign Up Key Stats Today's Range$4.70▼$4.9350-Day Range$4.23▼$5.1052-Week Range$1.58▼$5.59Volume3.78 million shsAverage Volume4.50 million shsMarket Capitalization$2.62 billionP/E Ratio493.49Dividend YieldN/APrice Target$5.10Consensus RatingHold Company Overview Clover Health Investments is a U.S. healthcare company focused on Medicare. Its insurance business offers Medicare Advantage plans to eligible beneficiaries in select markets, combining medical coverage with support intended to help members access care. The company also developed the Clover Assistant, a technology platform that organizes patient information and provides clinicians with insights to support care decisions. Clover has described the platform as a way to help primary care providers identify health needs and coordinate care for people with complex conditions. Founded in 2014, Clover Health became a publicly traded company in 2021 through a merger with a special purpose acquisition company. Andrew Toy serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Clover Health Investments Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreCLOV MarketRank™: 2.97546821419 of 5 starsClover Health Investments scored higher than 60% of companies evaluated by MarketBeat, and ranked 496th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingHold Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Clover Health Investments is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageClover Health Investments has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Clover Health Investments' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth166.67% Earnings GrowthEarnings for Clover Health Investments are expected to grow by 166.67% in the coming year, from $0.06 to $0.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is 493.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.27.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is 493.49, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.01.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 6.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.67% of the float of Clover Health Investments has been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 6.73.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 11.27%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. News and Social Media3.5 / 5News Sentiment0.67 News SentimentClover Health Investments has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 23 news articles for Clover Health Investments this week, compared to 4 articles on an average week.Search InterestOnly 6 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat Follows4 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,462,479.00 in company stock.Percentage Held by Insiders23.51% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions19.77% of the stock of Clover Health Investments is held by institutions.Read more about Clover Health Investments' insider trading history. Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLOV Stock News HeadlinesStock Traders Buy Large Volume of Clover Health Investments Call Options (NASDAQ:CLOV)3 hours ago | americanbankingnews.comTranscript : Clover Health Investments, Corp. Presents at 2026 UBS Global Healthcare Conference, Nov-09-2026 12:30 PMNovember 9 at 8:34 PM | marketscreener.comMDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. | Weiss Ratings (Ad)Clover Health Investments, Corp. (CLOV) Presents at 2026 UBS Global Healthcare Conference TranscriptNovember 9 at 6:00 PM | seekingalpha.comClover Health Investments, Corp. 2026 Q3 - Results - Earnings Call PresentationNovember 8 at 11:48 PM | seekingalpha.comCanaccord Genuity Reaffirms Their Buy Rating on Clover Health Investments (CLOV)November 6, 2026 | theglobeandmail.comClover Health Investments (NASDAQ:CLOV) Stock: Insider Karen Soares Sells 19,275 SharesOctober 21, 2026 | insidertrades.comClover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 14,673 Shares of StockOctober 20, 2026 | insidertrades.comSee More Headlines CLOV Stock Analysis - Frequently Asked Questions How have CLOV shares performed this year? Clover Health Investments' stock was trading at $2.35 on January 1st, 2026. Since then, CLOV shares have increased by 109.8% and is now trading at $4.93. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) posted its earnings results on Wednesday, November, 4th. The company reported $0.01 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.02. The firm had revenue of $759.30 million for the quarter, compared to the consensus estimate of $740.07 million. Clover Health Investments had a net margin of 0.45% and a trailing twelve-month return on equity of 4.66%. Read the conference call transcript. Who are Clover Health Investments' major shareholders? Top institutional investors of Clover Health Investments include Kestra Private Wealth Services LLC (0.05%), Russell Investments Group Ltd. (0.02%), State of Wyoming (0.02%) and Voya Investment Management LLC (0.02%). Insiders that own company stock include Andrew Toy, Brady Patrick Priest, Karen Soares, Conrad Wai, Carladenise Armbrister Edwards, Joseph Frank Oldakowski and Anna U Loengard. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Clover Health Investments own? Based on aggregate information from My MarketBeat watchlists, some other companies that Clover Health Investments investors own include Palantir Technologies (PLTR), Tesla (TSLA), AMC Entertainment (AMC), NVIDIA (NVDA), NIO (NIO), Advanced Micro Devices (AMD) and SNDL (SNDL). Company Calendar Last Earnings11/04/2026Today11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CLOV's financial health is in the Green zone, according to TradeSmith. CLOV has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNASDAQ:CLOV CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees724Year Founded2014Price Target and Rating Average Price Target for Clover Health Investments$5.10 High Price Target$6.00 Low Price Target$2.50 Potential Upside/Downside+3.4%Consensus RatingHold Rating Score (0-4)2.29 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)$0.01 Trailing P/E Ratio493.49 Forward P/E Ratio30.81 P/E GrowthN/ANet Income-$85.55 million Net Margins0.45% Pretax Margin0.45% Return on Equity4.66% Return on Assets2.43% Debt Debt-to-Equity RatioN/A Current Ratio1.55 Quick Ratio1.50 Sales & Book Value Annual Sales$1.92 billion Price / Sales1.36 Cash FlowN/A Price / Cash FlowN/A Book Value$0.74 per share Price / Book6.66Miscellaneous Outstanding Shares531,160,000Free Float406,281,000Market Cap$2.62 billion OptionableOptionable Beta2.52 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:CLOV) was last updated on 11/10/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredMy prediction for December 8thElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public co...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredYour Copy is Available to ClaimJames Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clover Health Investments With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLOV Stock Alerts